Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1449 in Diabetic Patients With Low HDL-Cholesterol
NCT01972477Phase 3Withdrawn
- Sponsor
- Dexa Medica
- Start
- Jul 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS1449 in hypoalphalipoproteinemia, sponsored by Dexa Medica. Planned start Jul 2016; status: withdrawn.
02
Drugs
DLBS1449
03
Conditions
hypoalphalipoproteinemia
Beyond the preview
Go deeper on NCT01972477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972477.